Dale Schaar is an Oncology physician affiliated with Rutgers. OpenAlex indexes 47 publications with 1,406 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
195 Little Albany St
New Brunswick, NJ 089011914
Telephone
732-235-2465Provider last certified this registry record 9 Apr 2024.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Kite Pharma, Inc.Program year20221 payment
- Novartis Pharmaceuticals CorporationProgram year20221 payment
- E.R. Squibb & Sons, L.L.C.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2009–2011 per NIH RePORTER. The latest:
- The Role of MicroRNAs in Human Hematopoietic Cell Differentiation
Univ of Med/dent Nj-R W Johnson Med Sch
FY2011$137,160K08HL092033 - The Role of MicroRNAs in Human Hematopoietic Cell Differentiation
Univ of Med/dent Nj-R W Johnson Med Sch
FY2010$137,160K08HL092033 - The Role of MicroRNAs in Human Hematopoietic Cell Differentiation
Univ of Med/dent Nj-R W Johnson Med Sch
FY2009$137,160K08HL092033
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A phase I study of MLN4924 and belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome
Cancer Chemotherapy and Pharmacology
2025 - Prophylactic Vancomycin in the Primary Prevention of <i>Clostridium difficile</i> in Allogeneic Stem Cell Transplant
Transplant Infectious Disease
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Reynold Panettieri, MD
Rutgers
Jacob Sage, MD
Rutgers
Brenda Kurnik, MD
Rutgers
Tudor Vagaonescu, MD
Rutgers
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”